Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia

Walaa Mohammedsaeed; Zain J Alghamdi

doi:10.15537/smj.2024.45.7.20240156

Article Information

vol. 45 no. 7 675-684

DOI

https://doi.org/10.15537/smj.2024.45.7.20240156

PubMed

38955454

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Received February 24, 2024
Accepted June 10, 2024
Published online July 1, 2024.

Copyright: © Saudi Medical Journal This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

Walaa Mohammedsaeed, MSc, PhD ⇑ and
Zain J Alghamdi, MD

From the Department of Clinical Laboratory Sciences (Mohammedsaeed), Faculty of Applied Medical Science,Taibah University; and from the Department of Endocrinology and Diabetes Center(Alghamdi), King Fahad Hospital, Al Madina Al Munawara, Kingdom of Saudi Arabia.

Address correspondence and reprint request to: Dr. Walaa Mohammedsaeed, Department of Clinical Laboratory Sciences, Faculty of Applied Medical Science,Taibah University, Taiba, Kingdom of Saudi Arabia. E-mail: wmohammedsaeed{at}taibahu.edu.sa

View Full Text